Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin

Experimental Dermatology

Volumn 15, Issue 7, 2006, Pages 509-514

  Kasraee, Behrooz ^a,b   Fallahi, Mohammad Reza ^c   Ardekani, Gholamreza Safaee ^c   Ebrahimi, Saeed ^c   Doroudchi, Gholamreza ^c   Omrani, Gholamhossein R ^a   Handjani, Farhad ^d   Amini, Mitra ^c   Tanideh, Nader ^d   Haddadi, Marzieh ^c   Nikbakhsh, Mohammad ^c   Jahanbani, Saeedeh ^c   Tran, Christian ^b   Sorg, Olivier ^b   Saurat, Jean Hilaire ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Benoquin; Glutathione S transferase; Monobenzone; Retinoic acid; Vitiligo

Indexed keywords

HYDROQUINONE; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DEPIGMENTATION; DRUG POTENTIATION; FEMALE; GUINEA PIG; MELANOCYTE; NONHUMAN; RANDOMIZATION; SKIN BIOPSY; VITILIGO;

ANIMALS; DERMATOLOGIC AGENTS; DRUG SYNERGISM; EPIDERMIS; FEMALE; GUINEA PIGS; HAIR COLOR; HYDROQUINONES; MELANINS; MELANOCYTES; SKIN PIGMENTATION; TRETINOIN;

EID: 33744800035     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00441.x     Document Type: Article

References (27)

1. Oliver E A, Schwartz L, Warren L H. Occupational leukoderma: Preliminary report. J Am Med Assoc 1939: 113: 927-932.
2. Oliver E A, Schwartz L, Warren L H. Occupational leukoderma. Arch Dermatol Syphilol 1940: 42: 993-998.
3. Klander J V, Kimmick J M. Occupational leukoderma with report of cases. Ind Med Surg 1953: 22: 106-111.
4. Lockhart R V, Lowenthal L J. Occupational leukoderma: A report of six cases observed in a South African factory. S Afr Med J 1949: 23: 861-867.
5. Peck S M, Sabotka H. Effect of monobenzyl hydroquinone on oxidase systems in vivo and in vitro. J Invest Dermatol 1941: 4: 325-332.
6. Denton C R, Lerner A B, Fitzpatrick T B. Inhibition of melanin formation by chemical agents. J Invest Dermatol 1952: 18: 119-135.
7. Grojean M F, Thivolet J, Perrot H. Acquired leukomelanoderma caused by topical depigmenting agents. Ann Dermatol Venereol 1982: 109: 641-647.
8. Boissy R E, Manga P. On the etiology of contact/occupational vitiligo. Pigment Cell Res 2004: 17: 208-214.
9. Forman L. A note on the depigmenting properties of monobenzylether of hydroquinone. Br J Dermatol 1953: 65: 406-411.
10. Lerner A B, Fitzpatrick T B. Treatment of melanin hyperpigmentation. J Am Med Assoc 1953: 152: 577-584.
11. Canizares O. Leukomelanoderma: Subsequent to the applications of monobenzylether of hydroquinone. Arch Dermatol 1958: 77: 220-225.
12. Arndt K A, Fitzpatrick T B. Topical use of hydroquinone as a depigmenting agent. J Am Med Assoc 1965: 194: 965-968.
13. Mosher D B, Parrish J A, Fitzpatrick T B. Monobenzylether of hydroquinone: A retrospective study of treatment of 18 vitiligo patients and a review of literature. Br J Dermatol 1977: 97: 669-679.
14. Radmanesh M. Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy. J Eur Acad Dermatol Venereol 2000: 14: 149-152.
15. Kligman A M, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975: 111: 40-48.
16. Orlow S J, Chakraborty A K, Pawelek J M. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990: 94: 461-464.
17. Nair X, Parab P, Suhr L, Tramposch K M. Combination of 4-hydroxyanisole and all- trans retinoic acid produces synergistic skin depigmentation in swine. J Invest Dermatol 1993: 101: 145-149.
18. Kasraee B, Tran C, Sorg O, Saurat J-H. The depigmenting effect of RALGA in C57BL/6 mice. Dermatology 2005: 210 (Suppl. 1): 30-34.
19. Kasraee B. Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents. Dermatology 2002: 205: 329-339.
20. Bolognia J L, Sodi S A, Osber M P, Pawelek J M. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine. Br J Dermatol 1995: 133: 349-357.
21. Kasraee B, Handjani F, Aslani F S. Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all- trans -retinoic acid (tretinoin): The impairment of glutathione-dependent cytoprotection? Dermatology 2003: 206:289-291.
22. Orlow S J, Chakraborty A K, Boissy R E, Pawelek J M. Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers. Exp Cell Res 1990: 191: 209-218.
23. Romero C, Aberdam E, Larnier C, Ortonne J P. Retinoic acid as modulator of UVB-induced melanogenic enzymes expression. J Cell Sci 1994: 107: 1095-1103.
24. Kasraee B, Hugin A, Tran C, Sorg O, Saurat J H. Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. J Invest Dermatol 2004: 122: 1338-1341.
25. Yoshimura K, Tsukamoto K, Okazaki M et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci 2001: 27 (Suppl. 1): S68-S75.
26. Fullerton A, Serup J. Characterization of irritant patch test reactions to topical D vitamins and all- trans- retinoic acid in comparison with sodium lauryl sulphate: Evaluation by clinical scoring and multiparametric non-invasive measuring techniques. Br J Dermatol 1997: 137: 234-240.
27. Gimeno A, Zaragoza R, Vivo-Sese I, Vina J R, Miralles V J. Retinol at concentrations greater than the physiological limit induces oxidative stress and apoptosis in human dermal fibroblasts. Exp Dermatol 2004: 13: 45-54.